Chester B. Whitley

7.8k citations

201 papers · 5.1k indexed · h-index 39

Physiology top 0.5%
Molecular Biology top 5%
Epidemiology top 2%
Rheumatology top 1%
Genetics top 2%

Co-authors: Elsa Shapiro Paul Harmatz Li Ou Elena L. Aronovich R. Scott McIvor Dao Pan Robert J. Gorlin Elizabeth Braunlin
Topics: Lysosomal Storage Disorders Research (142 papers)Glycogen Storage Diseases and Myoclonus (40 papers)Trypanosoma species research and implications (36 papers)
Cited by: Physiology Clinical Biochemistry Rheumatology
Journals: The Lancet Annals of Internal Medicine PLoS ONE
Partner nations: United States United Kingdom France

In The Last Decade

Chester B. Whitley

197 papers receiving 5.0k citations

Peers

Countries citing papers authored by Chester B. Whitley

Since Specialization

Citations

This map shows the geographic impact of Chester B. Whitley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester B. Whitley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester B. Whitley more than expected).

Fields of papers citing papers by Chester B. Whitley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chester B. Whitley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester B. Whitley. The network helps show where Chester B. Whitley may publish in the future.

Co-authorship network of co-authors of Chester B. Whitley

This figure shows the co-authorship network connecting the top 25 collaborators of Chester B. Whitley. A scholar is included among the top collaborators of Chester B. Whitley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chester B. Whitley. Chester B. Whitley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case series 2025 ·Communications Medicine ·Nishitha R. Pillai,Ning Liu,Xiyuan Li,Xiqi Li,Rebecca C. Ahrens‐Nicklas,Laura Adang,Julie B. Eisengart,(unknown),Ashish Gupta,Troy C. Lund,Chester B. Whitley,Sarah H. Elsea,Paul J. Orchard	0
2	Dose-intensive therapy (DIT) for infantile Pompe disease: A pilot study 2024 ·Molecular Genetics and Metabolism Reports ·(unknown),Nishitha R. Pillai,Alia Ahmed,(unknown),Michael J. Stark,Chester B. Whitley	0
3	Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I 2024 ·Molecular Therapy — Methods & Clinical Development ·Lalitha R. Belur,(unknown),(unknown),(unknown),(unknown),(unknown),Kelley F. Kitto,Ou Li,Chester B. Whitley,Elizabeth Braunlin,(unknown),Troy C. Lund,Davis Seelig,Carolyn A. Fairbanks,Nicholas Buss,(unknown),R. Scott McIvor	0
4	Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening 2023 ·Molecular Genetics and Metabolism ·Nishitha R. Pillai,(unknown),(unknown),(unknown),Alia Ahmed,Amy Hietala,Alissa Jorgenson,Brendan C. Lanpher,Chester B. Whitley	2
5	Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10‐year prospective study 2023 ·Journal of Inherited Metabolic Disease ·Bradley S. Miller,Ellen B. Fung,Klane K. White,Troy C. Lund,Paul Harmatz,Paul J. Orchard,Chester B. Whitley,Lynda E. Polgreen	5
6	Sanfilippo syndrome: consensus guidelines for clinical care 2022 ·Orphanet Journal of Rare Diseases ·Nicole Muschol,Roberto Giugliani,Simon Jones,Joseph Muenzer,Nicholas Smith,Chester B. Whitley,(unknown),(unknown),(unknown),Lisa Melton,(unknown),(unknown)	18
7	Agalsidase-Beta Therapy for Advanced Fabry Disease 2020 ·Annals of Internal Medicine ·Maryam Banikazemi,Jan Bultas,Stephen Waldek,William R. Wilcox,Chester B. Whitley,Timothy J. McDonald,Richard S. Finkel,Seymour Packman,Daniel G. Bichet,David G. Warnock,Robert J. Desnick	1
8	Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry 2019 ·Clinical Genetics ·L. Clarke,Roberto Giugliani,Nathalie Guffon,Simon Jones,Hillary A. Keenan,(unknown),Torayuki Okuyama,David Viskochil,Chester B. Whitley,Frits A. Wijburg,Joseph Muenzer	51
9	Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome 2018 ·Orphanet Journal of Rare Diseases ·Elsa Shapiro,Chester B. Whitley,Julie B. Eisengart	18
10	Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B 2018 ·The Journal of Pediatrics ·Chester B. Whitley,Maureen Cleary,Eugen Mengel,Paul Harmatz,Elsa Shapiro,Igor Nestrašil,Patrick Haslett,David Whiteman,(unknown)	25
11	Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison 2018 ·Genetics in Medicine ·Julie B. Eisengart,Kyle Rudser,Yong Xue,Paul J. Orchard,Weston P. Miller,Troy C. Lund,Ans van der Ploeg,Jean Mercer,Simon Jones,Eugen Mengel,(unknown),Nathalie Guffon,Roberto Giugliani,(unknown),Elsa Shapiro,Chester B. Whitley	43
12	Anesthetic care and perioperative complications in children with Sanfilipo Syndrome Type A 2016 ·Pediatric Anesthesia ·(unknown),David S. Beebe,Chester B. Whitley,Kumar G. Belani	8
13	Gene therapy for neurologic manifestations of mucopolysaccharidoses 2014 ·Expert Opinion on Drug Delivery ·Daniel Wolf,(unknown),Perry B. Hackett,Chester B. Whitley,R. Scott McIvor,Walter C. Low	35
14	Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler–Scheie syndrome 2013 ·Molecular Genetics and Metabolism ·Alia Ahmed,Chester B. Whitley,(unknown),Kyle Rudser,Stephanie Cagle,Nadia Ali,Kathleen Delaney,Brianna Yund,Elsa Shapiro	24
15	Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase 2010 ·Journal of Pediatric Rehabilitation Medicine ·Celeste Decker,Zi‐Fan Yu,Roberto Giugliani,Ida Vanessa Döederlein Schwartz,Nathalie Guffon,Elisa Leão Teles,Clara Sá-Miranda,J. E. Wraith,Michael Beck,Laila Arash,Maurizio Scarpa,David Ketteridge,John J. Hopwood,Barbara Plecko,Robert D. Steiner,Chester B. Whitley,Paige Kaplan,Stuart J. Swiedler,Susan E. Conrad,Paul Harmatz	52
16	Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome 2005 ·Genetics in Medicine ·Satkiran S. Grewal,Robert Wynn,José E. Abdenur,Barbara K. Burton,Maged I. Gharib,Claudia M. Haase,Robert J. Hayashi,Shalini Shenoy,David Sillence,George E. Tiller,(unknown),Annet van Royen‐Kerkhof,J. E. Wraith,Paul Woodard,Guy Young,Nico Wulffraat,Chester B. Whitley,Charles Peters	74
17	Canine Heparan Sulfate Sulfamidase and the Molecular Pathology Underlying Sanfilippo Syndrome Type A in Dachshunds 2000 ·Genomics ·Elena L. Aronovich,K. Paige Carmichael,Hiroki Morizono,Ioannis G. Koutlas,Minerva Deanching,George Hoganson,Andrea Fischer,Chester B. Whitley	20
18	Combined Ultrafiltration-Transduction in a Hollow-Fiber Bioreactor Facilitates Retrovirus-Mediated Gene Transfer into Peripheral Blood Lymphocytes from Patients with Mucopolysaccharidosis Type II 1999 ·Human Gene Therapy ·Dao Pan,(unknown),David F. Stroncek,Chester B. Whitley	9
19	Mobilization and Transduction of Peripheral Blood Progenitor Cells in Patients with Mucopolysaccharidosis I 1998 ·Journal of Hematotherapy ·Allison Hubel,David Stroncek,Dao Pan,Chester B. Whitley,Jeffrey McCullough	1
20	Retroviral-Mediated Transfer of the Iduronate-2-Sulfatase Gene into Lymphocytes for Treatment of Mild Hunter Syndrome (Mucopolysaccharidosis Type II). University of Minnesota Medical School, Minneapolis, Minnesota 1996 ·Human Gene Therapy ·Chester B. Whitley,R. Scott McIvor,Elena L. Aronovich,Susan A. Berry,Bruce R. Blazar,Scott R. Burger,John H. Kersey,Richard A. King,Anthony J. Faras,Richard E. Latchaw,Jeffrey McCullough,Dao Pan,Norma K.C. Ramsay,David F. Stroncek	27

About Chester B. Whitley

Chester B. Whitley is a scholar working on Physiology, Rheumatology and Physiology, having authored 201 papers that have together received 5.1k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (142 papers), Glycogen Storage Diseases and Myoclonus (40 papers) and Trypanosoma species research and implications (36 papers). The work is most often cited by research in Physiology (3.5k citations), Clinical Biochemistry (555 citations) and Rheumatology (908 citations). Chester B. Whitley has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Elsa Shapiro, Paul Harmatz, Li Ou, Elena L. Aronovich, R. Scott McIvor, Dao Pan, Robert J. Gorlin, Elizabeth Braunlin, Roland Günther and Brenda Koniar. Their work appears in journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact